Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Amortization of Deferred Charges (2016 - 2019)

Historic Amortization of Deferred Charges for Aethlon Medical (AEMD) over the last 9 years, with Q1 2019 value amounting to $30287.0.

  • Aethlon Medical's Amortization of Deferred Charges changed 0.0% to $30287.0 in Q1 2019 from the same period last year, while for Mar 2019 it was $121148.0, marking a year-over-year decrease of 5068.53%. This contributed to the annual value of $30287.0 for FY2020, which is 7500.0% down from last year.
  • Aethlon Medical's Amortization of Deferred Charges amounted to $30287.0 in Q1 2019, which was down 0.0% from $30287.0 recorded in Q4 2018.
  • In the past 5 years, Aethlon Medical's Amortization of Deferred Charges ranged from a high of $156597.0 in Q1 2016 and a low of $18998.0 during Q3 2016
  • In the last 5 years, Aethlon Medical's Amortization of Deferred Charges had a median value of $30287.0 in 2017 and averaged $73340.4.
  • In the last 5 years, Aethlon Medical's Amortization of Deferred Charges skyrocketed by 103095.96% in 2015 and then crashed by 8591.9% in 2016.
  • Over the past 5 years, Aethlon Medical's Amortization of Deferred Charges (Quarter) stood at $134919.0 in 2015, then plummeted by 85.92% to $18998.0 in 2016, then surged by 59.42% to $30287.0 in 2017, then changed by 0.0% to $30287.0 in 2018, then changed by 0.0% to $30287.0 in 2019.
  • Its Amortization of Deferred Charges stands at $30287.0 for Q1 2019, versus $30287.0 for Q4 2018 and $30287.0 for Q3 2018.